Spero Therapeutics is based out of Cambridge. Spero Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on identifying, developing, and commercializing novel treatments for MDR bacterial infections. Spero Therapeutics also offers a technology platform that develops drugs to expand the spectrum and potency of existing antibiotics. Spero Therapeutics serves customers worldwide. The firm last filed a Form D notice of exempt offering of securities on 2022-11-15. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Spero Therapeutics, Inc.675 MASSACHUSETTS AVENUE
CAMBRIDGE MA 02139
Business Phone: 857-242-1600
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS